Chargement en cours...

The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China

AIM: To explore the process of retinal vascularization and risk factors for retinopathy of prematurity (ROP) treated with intravitreal ranibizumab (IVR) as monotherapy. METHODS: Infants with type 1 ROP who received IVR as primary treatment from August 2014 to October 2016 at Peking University People...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Ophthalmol
Auteurs principaux: Meng, Qing-Yu, Cheng, Yong, Zhao, Ming-Wei, Liang, Jian-Hong
Format: Artigo
Langue:Inglês
Publié: International Journal of Ophthalmology Press 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629800/
https://ncbi.nlm.nih.gov/pubmed/31341806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2019.07.15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!